Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080649974> ?p ?o ?g. }
- W2080649974 endingPage "1302" @default.
- W2080649974 startingPage "1296" @default.
- W2080649974 abstract "Objectives To compare overall and prostate cancer-specific survival, using the Detroit Surveillance, Epidemiology, and End Results registry data, among 8679 Detroit area black and white men with localized or regional stage prostate cancer diagnosed from 1988 to 1992 to determine whether racial disparities in long-term survival remained after adjusting for treatment type and socioeconomic status (SES). Methods The cases were geocoded to the census block-group, and SES data were obtained from the 1990 U.S. Census. Cox proportional hazards regression analysis was used to estimate the hazard ratio of death from any cause. The median follow-up was 16.5 years. Results Of the 7770 localized stage cases (22% black and 78% white) and 909 regional cases (24% black and 76% white), black men were more likely to receive nonsurgical treatment (P < .001) and to be of low SES (P < .0001). The survival analyses were stratified by stage. For both stages, black men had poorer survival than white men in the unadjusted model. The adjustment for age and tumor grade had little effect on the survival differences, but adjustment for SES and treatment removed the survival differences. Conclusions Low SES and nonsurgical treatment were associated with a greater risk of death among men with prostate cancer, explaining much of the survival disadvantage for black men with prostate cancer. To compare overall and prostate cancer-specific survival, using the Detroit Surveillance, Epidemiology, and End Results registry data, among 8679 Detroit area black and white men with localized or regional stage prostate cancer diagnosed from 1988 to 1992 to determine whether racial disparities in long-term survival remained after adjusting for treatment type and socioeconomic status (SES). The cases were geocoded to the census block-group, and SES data were obtained from the 1990 U.S. Census. Cox proportional hazards regression analysis was used to estimate the hazard ratio of death from any cause. The median follow-up was 16.5 years. Of the 7770 localized stage cases (22% black and 78% white) and 909 regional cases (24% black and 76% white), black men were more likely to receive nonsurgical treatment (P < .001) and to be of low SES (P < .0001). The survival analyses were stratified by stage. For both stages, black men had poorer survival than white men in the unadjusted model. The adjustment for age and tumor grade had little effect on the survival differences, but adjustment for SES and treatment removed the survival differences. Low SES and nonsurgical treatment were associated with a greater risk of death among men with prostate cancer, explaining much of the survival disadvantage for black men with prostate cancer." @default.
- W2080649974 created "2016-06-24" @default.
- W2080649974 creator A5002476840 @default.
- W2080649974 creator A5036375446 @default.
- W2080649974 creator A5044454029 @default.
- W2080649974 creator A5053628444 @default.
- W2080649974 creator A5065040812 @default.
- W2080649974 creator A5087618277 @default.
- W2080649974 date "2009-12-01" @default.
- W2080649974 modified "2023-09-23" @default.
- W2080649974 title "Interplay of Race, Socioeconomic Status, and Treatment on Survival of Patients With Prostate Cancer" @default.
- W2080649974 cites W1544904312 @default.
- W2080649974 cites W1941234749 @default.
- W2080649974 cites W1964591739 @default.
- W2080649974 cites W1975082129 @default.
- W2080649974 cites W1976795083 @default.
- W2080649974 cites W2007769372 @default.
- W2080649974 cites W2014467318 @default.
- W2080649974 cites W2018500647 @default.
- W2080649974 cites W2018672277 @default.
- W2080649974 cites W2027032188 @default.
- W2080649974 cites W2051806901 @default.
- W2080649974 cites W2055731134 @default.
- W2080649974 cites W2056939962 @default.
- W2080649974 cites W2064979057 @default.
- W2080649974 cites W2078486195 @default.
- W2080649974 cites W2100215663 @default.
- W2080649974 cites W2103429819 @default.
- W2080649974 cites W2110733906 @default.
- W2080649974 cites W2117090889 @default.
- W2080649974 cites W2120449957 @default.
- W2080649974 cites W2131167586 @default.
- W2080649974 cites W2137213403 @default.
- W2080649974 cites W2151778057 @default.
- W2080649974 cites W49147271 @default.
- W2080649974 doi "https://doi.org/10.1016/j.urology.2009.02.058" @default.
- W2080649974 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2791874" @default.
- W2080649974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19962532" @default.
- W2080649974 hasPublicationYear "2009" @default.
- W2080649974 type Work @default.
- W2080649974 sameAs 2080649974 @default.
- W2080649974 citedByCount "97" @default.
- W2080649974 countsByYear W20806499742012 @default.
- W2080649974 countsByYear W20806499742013 @default.
- W2080649974 countsByYear W20806499742014 @default.
- W2080649974 countsByYear W20806499742015 @default.
- W2080649974 countsByYear W20806499742016 @default.
- W2080649974 countsByYear W20806499742017 @default.
- W2080649974 countsByYear W20806499742018 @default.
- W2080649974 countsByYear W20806499742019 @default.
- W2080649974 countsByYear W20806499742020 @default.
- W2080649974 countsByYear W20806499742021 @default.
- W2080649974 countsByYear W20806499742022 @default.
- W2080649974 countsByYear W20806499742023 @default.
- W2080649974 crossrefType "journal-article" @default.
- W2080649974 hasAuthorship W2080649974A5002476840 @default.
- W2080649974 hasAuthorship W2080649974A5036375446 @default.
- W2080649974 hasAuthorship W2080649974A5044454029 @default.
- W2080649974 hasAuthorship W2080649974A5053628444 @default.
- W2080649974 hasAuthorship W2080649974A5065040812 @default.
- W2080649974 hasAuthorship W2080649974A5087618277 @default.
- W2080649974 hasBestOaLocation W20806499742 @default.
- W2080649974 hasConcept C10515644 @default.
- W2080649974 hasConcept C107130276 @default.
- W2080649974 hasConcept C121608353 @default.
- W2080649974 hasConcept C126322002 @default.
- W2080649974 hasConcept C143998085 @default.
- W2080649974 hasConcept C144024400 @default.
- W2080649974 hasConcept C146357865 @default.
- W2080649974 hasConcept C147077947 @default.
- W2080649974 hasConcept C149923435 @default.
- W2080649974 hasConcept C151730666 @default.
- W2080649974 hasConcept C207103383 @default.
- W2080649974 hasConcept C2778527826 @default.
- W2080649974 hasConcept C2779391198 @default.
- W2080649974 hasConcept C2780192828 @default.
- W2080649974 hasConcept C2908647359 @default.
- W2080649974 hasConcept C29456083 @default.
- W2080649974 hasConcept C44249647 @default.
- W2080649974 hasConcept C50382708 @default.
- W2080649974 hasConcept C71924100 @default.
- W2080649974 hasConcept C74909509 @default.
- W2080649974 hasConcept C86803240 @default.
- W2080649974 hasConcept C99454951 @default.
- W2080649974 hasConceptScore W2080649974C10515644 @default.
- W2080649974 hasConceptScore W2080649974C107130276 @default.
- W2080649974 hasConceptScore W2080649974C121608353 @default.
- W2080649974 hasConceptScore W2080649974C126322002 @default.
- W2080649974 hasConceptScore W2080649974C143998085 @default.
- W2080649974 hasConceptScore W2080649974C144024400 @default.
- W2080649974 hasConceptScore W2080649974C146357865 @default.
- W2080649974 hasConceptScore W2080649974C147077947 @default.
- W2080649974 hasConceptScore W2080649974C149923435 @default.
- W2080649974 hasConceptScore W2080649974C151730666 @default.
- W2080649974 hasConceptScore W2080649974C207103383 @default.
- W2080649974 hasConceptScore W2080649974C2778527826 @default.
- W2080649974 hasConceptScore W2080649974C2779391198 @default.
- W2080649974 hasConceptScore W2080649974C2780192828 @default.